Your search returned 34 studies. (Get alerts for new studies):
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
2 Locations available
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
227 Locations available
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lym
Conditions: Leukemia - Lymphoma
1 Location available
- Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
Conditions: Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome - Hodgkin's Lymphoma - Non-Hodgkin's Disease - Acute Leukemia - Multiple Myeloma
1 Location available
- Genetic Epidemiology of Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin - Leukemia, Lymphocytic, Chronic, B-Cell - Lymphoma, B-Cell
1 Location available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Effectiveness of a Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN #0701
Conditions: Lymphoma, Non-Hodgkin
34 Locations available
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-
Conditions: Renal Cell Carcinoma - Non-hodgkin's Lymphoma
5 Locations available
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Conditions: Non-Hodgkin's Lymphoma - Hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
10 Locations available
- Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
8 Locations available
- A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
Conditions: Acute Lymphoblastic Leukemia - Acute Myeloid Leukemia - Chronic Myeloid Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin'
Conditions: Non-Hodgkin's Lymphoma - Mantle Cell Lymphoma
27 Locations available
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, Follicular
6 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
11 Locations available
- Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Conditions: Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
6 Locations available
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
5 Locations available
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
Conditions: Lymphoma, Non-Hodgkin
9 Locations available
- Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Conditions: Non-Hodgkin's Lymphoma - B-cell Lymphoma
1 Location available
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
13 Locations available
- Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Conditions: Chronic Lymphocytic Leukemia - B-Cell Non-Hodgkin's Lymphoma
1 Location available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- Unrelated Donor Stem Cell Transplantation
Conditions: Severe Aplastic Anemia - Paroxysmal Nocturnal Hemoglobinuria - Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Myelodysplastic Syndromes - Myeloproliferative Syndromes - Chronic Myelogenous Leukemia - Hodgkin's Lymphoma - Non-Hodgkin's Lymphom
1 Location available
- Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent G
1 Location available
- Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Ly
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Conditions: Hematologic Malignancy - Leukemia - Acute Lymphoblastic Leukemia - ALL - Acute Myelogenous Leukemia - AML - Chronic Lymphocytic Leukemia - CLL - Lymphoma - Hodgkin's Lymphoma - Non-hodgkin's Lymphoma - Myeloma
1 Location available
|